窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 30 2025

Full Issue

Opioid Use Disorder Diagnoses Surged Nationwide Between 2021 And 2024

Tennessee had the highest rate, with 1,447 patients diagnosed with opioid use disorder per 100,000, Axios reports. Also in the news: Gabapentin use rises, GLP-1 meds are tied to lower cancer risk, and more.

Diagnoses of opioid use disorder among the commercially insured jumped nearly 40% nationwide between 2021 and 2024, according to data from FAIR Health's Opioid Tracker shared first with Axios. (Reed, 9/30)

More pharmaceutical news

Gabapentin prescribing rose sharply in recent years, with the generic drug becoming the fifth most dispensed product in retail pharmacies in 2024, a CDC analysis showed. From 2010 to 2024, prescriptions jumped from 79.5 to 177.6 per 1,000 people, according to Gery Guy Jr., PhD, of the CDC National Center for Injury Prevention and Control, and co-authors. (George, 8/29)

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs officially known as glucagon-like peptide 1 receptor agonists are associated with a reduced risk of some cancers, especially in women. (Stabile, 9/29)

Ameta-trial of randomized clinical studies conducted in 6 countries suggests that the use of inhaled heparin dramatically reduced the risk of intubation, death, and in-hospital death in hospitalized COVID-19 patients. (Van Beusekom, 9/29)

In health care industry news

Universal Health Services faces more than $500 million in damages after a Nevada jury ruled the system had interfered with Prime Healthcare physicians contracts. The lawsuit, which was filed in Washoe County, Nevada, in 2021, stems from Primes allegations that UHS illegally solicited physicians and other employees from Saint Marys Medical Group, stole trade secrets, diverted patients and triggered a mass resignation to gain an economic advantage, according to a Monday press release from Prime. (Hudson, 9/29)

Yale New Haven Health will pay Prospect Medical Holdings $45 million to settle dueling lawsuits in state court, ending a contentious saga over the proposed sale of Prospects three Connecticut hospitals with Yale acquiring none of them. (Altimari, 9/29)

窪蹋勛圖厙 News: Doctors With TroubledPasts Are Performing Cosmetic Surgeries Tied To Crippling Pain And Injury

Not long after California surgeon Andrew S. Hsu landed a job with a cosmetic surgery chain in Georgia, several of his patients suffered disfiguring injuries, and even his new employer had doubts about his competence, court records allege. Hsu, a board-certified general surgeon, was one of six out-of-state doctors who joined the Atlanta Goals Aesthetics & Plastic Surgery center during the pandemic. (Schulte, 9/30)

窪蹋勛圖厙 News: How To Pick The Right Cosmetic Surgeon

The debate over which doctors are best qualified to perform cosmetic surgery and who gets the best results for patients has raged for decades. Heres why: A state-issued medical license grants a physician what a Federation of State Medical Boards policy statement called the privilege of practicing the full breadth of medicine. (Schulte, 9/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF